valsartan has been researched along with Vascular Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, L; Cao, Z; Guo, Q; Huang, Q; Li, W; Liu, X; Zeng, R | 1 |
| Ikeda, H; Jin, D; Miyazaki, M; Sakonjo, H; Takai, S | 1 |
| Janic, M; Lunder, M; Sabovic, M | 1 |
| Aritomi, S; Jin, D; Miyazaki, M; Niinuma, K; Takai, S | 1 |
1 trial(s) available for valsartan and Vascular Diseases
| Article | Year |
|---|---|
Reduction of age-associated arterial wall changes by low-dose valsartan.
Topics: Adult; Age Factors; Aging; Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Brachial Artery; Carotid Artery, Common; Double-Blind Method; Heart Rate; Humans; Male; Pulse Wave Analysis; Slovenia; Tetrazoles; Time Factors; Treatment Outcome; Ultrasonography; Valine; Valsartan; Vascular Diseases; Vascular Stiffness; Vasodilation | 2012 |
3 other study(ies) available for valsartan and Vascular Diseases
| Article | Year |
|---|---|
Valsartan alleviates the blood-brain barrier dysfunction in db/db diabetic mice.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Blood-Brain Barrier; Brain; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Endothelial Cells; Inflammation; Male; Mice; Valsartan; Vascular Diseases | 2021 |
Significance of angiotensin II receptor blockers with high affinity to angiotensin II type 1 receptors for vascular protection in rats.
Topics: Acetylcholine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Carotid Arteries; Hypertension; Imidazoles; Immunohistochemistry; In Vitro Techniques; Male; Muscle Relaxation; NADPH Oxidases; Peptidyl-Dipeptidase A; Protective Agents; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Renin; Reverse Transcriptase Polymerase Chain Reaction; Sodium-Hydrogen Exchanger 3; Sodium-Hydrogen Exchangers; Tetrazoles; Valine; Valsartan; Vascular Diseases | 2009 |
Powerful vascular protection by combining cilnidipine with valsartan in stroke-prone, spontaneously hypertensive rats.
Topics: Aldehydes; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, N-Type; Carotid Arteries; Cysteine Proteinase Inhibitors; Dihydropyridines; Heart; Immunohistochemistry; Male; Muscle Relaxation; Muscle, Smooth, Vascular; NADH, NADPH Oxidoreductases; NADPH Oxidase 1; Nitric Oxide Synthase Type III; Organ Size; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Real-Time Polymerase Chain Reaction; Tetrazoles; Valine; Valsartan; Vascular Diseases | 2013 |